- Home
- / Alterity Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Alterity Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-28
Market Capitalization
$15.7 M
2024-10-28
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 3.1M | 5.0M | 123.0K | 4.5M | 5.1M | 3.9M | 4.0M | 7.6M |
| Operating expense total | 11.3M | 17.7M | 13.8M | 19.5M | 20.6M | 18.5M | 23.5M | 20.0M |
| Depreciation and amortization | 22.0K | 30.0K | 112.0K | 75.0K | 54.0K | 102.0K | 148.0K | 141.0K |
| EBITDA | (8.2M) | (12.8M) | (13.7M) | (15.0M) | (15.4M) | (14.5M) | (19.5M) | (12.3M) |
| EBIT | (8.2M) | (12.8M) | (13.8M) | (15.0M) | (15.5M) | (14.6M) | (19.6M) | (12.5M) |
| Interest income | 201.0K | 109.0K | 17.0K | 20.0K | 3.0K | 16.0K | 268.0K | 446.0K |
| Pre tax profit | (8.3M) | (12.3M) | (13.5M) | (15.3M) | (12.8M) | (13.7M) | (19.1M) | (12.1M) |
| Income tax expense | 70.0K | 104.0K | 46.0K | 68.0K | ||||
| Net Income | (8.3M) | (12.3M) | (13.5M) | (15.3M) | (12.8M) | (13.8M) | (19.1M) | (12.1M) |